Bioniz Therapeutics

Caldera Therapeutics

This clinical-stage biotechnology company develops bispecific antibodies to treat patients with inflammatory bowel disease and other immune-mediated conditions.

Reverb Therapeutics

This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Boulevard Bio

This clinical-stage biotechnology company develops multi-specific antibody therapies for patients suffering from B cell-driven autoimmune diseases.

Bright Peak Therapeutics

This biotechnology company develops engineered cytokine immunotherapies and immunoconjugates to treat patients with cancer and autoimmune diseases.

Bionyra Pharma

Bionyra Pharma develops mono and multispecific antibodies for patients with severe immune-mediated inflammatory diseases, including atopic dermatitis and inflammatory bowel disease.

Attovia Therapeutics

The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.

Kezar Life Sciences

This clinical-stage biopharmaceutical company develops small-molecule therapeutics for patients with autoimmune diseases and inflammatory conditions.